- ER-Kim Gains Exclusive Rights to Commercialize QRX003 Across Central & Eastern Europe - Fifth Distribution Partnership Established Since Quoin’s…
Bacterial biofilms on prostheses limit conventional antibiotic treatments of biofilm-based infectionsWINNIPEG, Manitoba, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Kane Biotech…
SAN FRANCISCO, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to improve…
CAMBRIDGE, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ: MRSN) a clinical-stage biopharmaceutical company focused on discovering…
Dr. Sessa Will Discuss the Promise of Psychedelic Medicine in Treating AddictionToronto, Ontario--(Newsfile Corp. - February 10, 2022) - Awakn…
Strategic partnership will offer breakthrough remote patient monitoring and virtual care solution across sixteen states FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems,…
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser…
Social Risk Intelligence Pioneer Welcomes Paul Matsui as Chief Strategy Officer and Mike Considine as Chief Product Officer WASHINGTON--(BUSINESS WIRE)--Socially…
Patient Management Platform Combines Clinically Proven Continuous Remote Monitoring, Full-Featured Video-Based Virtual Consultations, EMR Connectivity, and More IRVINE, Calif.--(BUSINESS WIRE)--Masimo…
Full Year 2021 vs. Full Year 2020: Net Revenues: $102.4 million, a 5% increase Net Income: $1.4 million, Adjusted EBITDA:…